Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01235923).
- Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized Trial Comparing EmbryoScope With EmbryoScope+.: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial Comparing EmbryoScope With EmbryoScope+.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522350).
- Randomized Trial for Botox Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial for Botox Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178191).
- Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized Trial of Diphenhydramine Versus Continued Midazolam in “Difficult-to-sedate” Patients Undergoing Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Diphenhydramine Versus Continued Midazolam in "Difficult-to-sedate" Patients Undergoing Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs: primary endpoint results, effect estimate…
- Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Randomized, Double-Blind, Placebo Controlled Study of Vilazodone’s Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection: primary endpoint results, effect estimate with confidence…
- Ranolazine and Pulmonary Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Ranolazine and Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01174173).
- RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: Complete Statistical AnalysisIndependent statistical analysis of RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00126672).
- RAPIDIndependent statistical analysis of Reducing Adenoviral Patient Infected Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472223).
- Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Rapid Diagnostic Assay for Gonorrhea and Chlamydia: Complete Statistical AnalysisIndependent statistical analysis of Rapid Diagnostic Assay for Gonorrhea and Chlamydia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564299).
- Rapid Flu Tests in Travelers With Fever: Complete Statistical AnalysisIndependent statistical analysis of Rapid Flu Tests in Travelers With Fever: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00821626).
- Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures: Complete Statistical AnalysisIndependent statistical analysis of Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01898208).
- Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51: Complete Statistical AnalysisIndependent statistical analysis of Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595790).
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP: Complete Statistical AnalysisIndependent statistical analysis of Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RAPID KORIndependent statistical analysis of Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Rapid Non-Invasive Brain Stimulation for OCD (oTMS): Complete Statistical AnalysisIndependent statistical analysis of Rapid Non-Invasive Brain Stimulation for OCD (oTMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03404609).
- Rapid Turnaround, Home-based Saliva Testing for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Rapid Turnaround, Home-based Saliva Testing for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04568122).
- RAPIDAIndependent statistical analysis of Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RAPIDS-GNIndependent statistical analysis of Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03218397).
- RAPTIndependent statistical analysis of Rapalogues for Autism Phenotype in TSC: A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01929642).
- RAPTIVAIndependent statistical analysis of Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00672204).
- RAS and Coagulopathy in COVID19: Complete Statistical AnalysisIndependent statistical analysis of RAS and Coagulopathy in COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04419610).
- RAS-HIVIndependent statistical analysis of Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02606279).
- Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS): Complete Statistical AnalysisIndependent statistical analysis of Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01786603).
- Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: Complete Statistical AnalysisIndependent statistical analysis of Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rasburicase in Patients at Risk for Tumor Lysis Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Rasburicase in Patients at Risk for Tumor Lysis Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00628628).
- Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02132767).
- Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: Complete Statistical AnalysisIndependent statistical analysis of Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RATE-RAIndependent statistical analysis of A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Rates of Middle Meatus Synechiae Formation Post Endoscopic Sinus Surgery: Complete Statistical AnalysisIndependent statistical analysis of Rates of Middle Meatus Synechiae Formation Post Endoscopic Sinus Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02627794).
- RAVENSIndependent statistical analysis of RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037358).
- Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis: Complete Statistical AnalysisIndependent statistical analysis of Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04999020).
- RCRPRFMIndependent statistical analysis of Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RCTIndependent statistical analysis of The Effectiveness of Brushing and Flossing Sequence on Control of Plaque and Gingival Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: Complete Statistical AnalysisIndependent statistical analysis of RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RCT of CBD for Anxiety in Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of RCT of CBD for Anxiety in Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04482244).
- RDEBIndependent statistical analysis of A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RDRIndependent statistical analysis of tDCS Effects on Resisting Smoking: Dose Ranging Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02624284).
- RE-COVER IIIndependent statistical analysis of Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE): primary endpoint results, effect estimate…
- RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: Complete Statistical AnalysisIndependent statistical analysis of Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534897).
- Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: Complete Statistical AnalysisIndependent statistical analysis of Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00675103).